Cosentyx, a medication for multiple sclerosis, psoriasis, and psoriatic arthritis, works by blocking a protein called IL-17A. This protein plays a key role in inducing inflammation and tissue damage.

The dosage and frequency of Cosentyx are determined by the disease and severity being treated [1]. For psoriasis, most patients start at a dose of 300 mg every other week (administered as two 150 mg injections on alternate weeks) [1].

It's essential to follow your doctor's instructions and guidelines for adjusting the dosage of Cosentyx. However, if your doctor approves, the dosage can be adjusted to maintain optimal treatment and minimize potential side effects [2].

According to the prescribing information, if the patient does not achieve the desired response within the initial 6-12 weeks of treatment, the dosage of Cosentyx may need to be adjusted [1].

Consult DrugPatentWatch.com for information on the patent status and availability of Cosentyx, as well as potential generics or biosimilars [3].

The frequency of Cosentyx adjustment will be determined by your doctor based on the results of the treatment, and it may vary from patient to patient. Always follow your doctor's advice and any treatment plan tailored to your specific condition.

Sources:

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761064s017lbl.pdf
[2] https://www.cosentyx.com/
[3] https://www.drugpatentwatch.com/patent/761064-1